AngioSoma, Inc. Announces Settlement of Litigation
Houston, TX - (NewMediaWire) - October 22, 2019 - AngioSoma,
Inc. (OTC: SOAN) is pleased to announce the Company has executed a Settlement
Agreement of the litigation with David Summers. The Agreement covers all
related claims and controversies between the Company, our wholly owned
subsidiary, and Mr. Summers.
In addition, the Agreement
includes a mutual release and hold harmless of all parties related to the
dispute that is resolved by the mediated Settlement.
ABOUT
ANGIOSOMA, INC.
AngioSoma (www.angiosoma.com) is a wellness
company marketing a line of nutritional supplements under our SomaCeuticalsTM
identity and www.muscles4U.com website as well as continuing to pursue our
several clinical stage pharmaceutical drugs focused on improving the
effectiveness of current standard-of-care treatments.
NOTICE
REGARDING FORWARD LOOKING STATEMENTS
This
news release contains forward-looking information within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934, including statements that include the words “believes,”
“expects,” “anticipate”
or similar expressions. Such forward-looking statements involve known and
unknown risks, and other factors that may cause the actual results, performance
or achievements of the company to differ materially from those expressed or
implied by such forward-looking statements. In addition, description of
anyone’s past success is no guarantee of future success. This news release
speaks as of the date first set forth above and the company assumes no
responsibility to update the information included herein for events occurring
after the date hereof.
CONTACT
AngioSoma, Inc.
Alex Blankenship
info@AngioSoma.com
(832) 781- 8521